Markerless Motion Capture to Quantify Functional Performance in Neurodegeneration: Systematic Review
- PMID: 39106477
- PMCID: PMC11336506
- DOI: 10.2196/52582
Markerless Motion Capture to Quantify Functional Performance in Neurodegeneration: Systematic Review
Abstract
Background: Markerless motion capture (MMC) uses video cameras or depth sensors for full body tracking and presents a promising approach for objectively and unobtrusively monitoring functional performance within community settings, to aid clinical decision-making in neurodegenerative diseases such as dementia.
Objective: The primary objective of this systematic review was to investigate the application of MMC using full-body tracking, to quantify functional performance in people with dementia, mild cognitive impairment, and Parkinson disease.
Methods: A systematic search of the Embase, MEDLINE, CINAHL, and Scopus databases was conducted between November 2022 and February 2023, which yielded a total of 1595 results. The inclusion criteria were MMC and full-body tracking. A total of 157 studies were included for full-text screening, out of which 26 eligible studies that met the selection criteria were included in the review. .
Results: Primarily, the selected studies focused on gait analysis (n=24), while other functional tasks, such as sit to stand (n=5) and stepping in place (n=1), were also explored. However, activities of daily living were not evaluated in any of the included studies. MMC models varied across the studies, encompassing depth cameras (n=18) versus standard video cameras (n=5) or mobile phone cameras (n=2) with postprocessing using deep learning models. However, only 6 studies conducted rigorous comparisons with established gold-standard motion capture models.
Conclusions: Despite its potential as an effective tool for analyzing movement and posture in individuals with dementia, mild cognitive impairment, and Parkinson disease, further research is required to establish the clinical usefulness of MMC in quantifying mobility and functional performance in the real world.
Keywords: Parkinson's disease; body tracking; clinical decision making; decision; decision making; dementia; markerless motion capture; mild cognitive impairment; mobility; monitoring; motion; motion analysis; movement; movement analysis; neurodegeneration; neurodegenerative; neurodegenerative disease; systematic review; tool; tracking.
©Julian Jeyasingh-Jacob, Mark Crook-Rumsey, Harshvi Shah, Theresita Joseph, Subati Abulikemu, Sarah Daniels, David J Sharp, Shlomi Haar. Originally published in JMIR Aging (https://aging.jmir.org), 06.08.2024.
Conflict of interest statement
Conflicts of Interest: None declared.
Figures
References
-
- Mentiplay BF, Perraton LG, Bower KJ, Pua YH, McGaw R, Heywood S, Clark RA. Gait assessment using the Microsoft Xbox One Kinect: concurrent validity and inter-day reliability of spatiotemporal and kinematic variables. J Biomech. 2015;48(10):2166–2170. doi: 10.1016/j.jbiomech.2015.05.021.S0021-9290(15)00298-5 - DOI - PubMed
-
- Clark RA, Pua YH, Oliveira CC, Bower KJ, Thilarajah S, McGaw R, Hasanki K, Mentiplay BF. Reliability and concurrent validity of the Microsoft Xbox One Kinect for assessment of standing balance and postural control. Gait Posture. 2015;42(2):210–213. doi: 10.1016/j.gaitpost.2015.03.005.S0966-6362(15)00074-0 - DOI - PubMed
-
- Ma Y, Liu D, Cai L. Deep learning-based upper limb functional assessment using a single Kinect v2 sensor. Sensors (Basel) 2020;20(7):1903. doi: 10.3390/s20071903. https://www.mdpi.com/resolver?pii=s20071903 s20071903 - DOI - PMC - PubMed
-
- Rammer JR, Krzak JJ, Riedel SA, Harris GF. Evaluation of upper extremity movement characteristics during standardized pediatric functional assessment with a Kinect®-based markerless motion analysis system. Annu Int Conf IEEE Eng Med Biol Soc. 2014;2014:2525–2528. doi: 10.1109/EMBC.2014.6944136. https://europepmc.org/abstract/MED/25570504 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous